Bettina Hoeppner, PhD, MS is the Director of Research of the MGH Recovery Research Institute at Mass General, a statistician at the MGH Clinical Trials Network & Institute and an Associate Professor in Psychology at Harvard Medical School. She is an experimental psychologist, and her research focuses on mHealth technologies, smoking cessation, and engagement in auxiliary addiction services (e.g., mutual help, recovery community centers). The overarching goal of her research is to improve access to care for persons seeking to overcome problematic substance use.
-
In adults with moderate to severe depression, heated yoga sessions delivered over an 8 week period were associated with clinically significant reductions in depressive symptoms. -
Peripartum toxicology testing is disproportionately performed on non-white, younger, and publicly insured mothers and their infants. -
While most adults had a stable pattern of use over the first year, about 13% of the participants in this study had an escalating pattern […] -
Benzodiazepine use did not impact treatment response; however, in patients on higher benzodiazepine dosage, ketamine may be less effective at first.